SCHEMBL564666

SCHEMBL564666

N#CCCC(C#N)C(Br)Br

nearest known ligand 0.44

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.44
ALDH1A1 P00352 2/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17935656 0.83 TSHR (0.52) TSHRALDH1A1TDP1
SCHEMBL28282352 0.80 TSHR (0.52) TSHRALDH1A1TDP1
SCHEMBL16257477 0.74 TSHR (0.50) TSHRALDH1A1TDP1
SCHEMBL5531904 0.72
SCHEMBL22613722 0.72 TSHR (0.48) TSHRALDH1A1TDP1
SCHEMBL27343568 0.71
Methane SCHEMBL2761950 0.70
SCHEMBL820231 0.69 TSHR (0.39) TSHRALDH1A1TDP1
Bromomethane SCHEMBL223765 0.68 TSHR (0.50) TSHRALDH1A1TDP1
SCHEMBL466784 0.68 TSHR (0.44) TSHRALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11835532-B2 Green concentrated reagent for hemotology systems BECKMAN COULTER, INC. (US) 2023-12-05 US claimed
CN-116120396-A Polypeptide and application thereof in preparation of preservative 华南协同创新研究院 2023-05-16 CN claimed
EP-3794346-B1 GREEN CONCENTRATED REAGENT FOR HEMATOLOGY SYSTEMS BECKMAN COULTER INC (US) 2023-03-08 EP claimed
US-20230047876-A1 GREEN CONCENTRATED REAGENT FOR HEMOTOLOGY SYSTEMS BECKMAN COULTER, INC. 2023-02-16 US claimed
US-11519921-B2 Green concentrated reagent for hematology systems BECKMAN COULTER, INC. (US) 2022-12-06 US claimed
US-20210231687-A1 GREEN CONCENTRATED REAGENT FOR HEMATOLOGY SYSTEMS BECKMAN COULTER, INC. 2021-07-29 US claimed
EP-3794346-A1 GREEN CONCENTRATED REAGENT FOR HEMATOLOGY SYSTEMS Beckman Coulter, Inc. (US) 2021-03-24 EP claimed
CN-112166322-A Green concentrated reagent for hematology system 拜克门寇尔特公司 2021-01-01 CN claimed
US-20190269129-A1 COMPOSITION CONTAINING 1,2-DIBROMO-2,4-DICYANOBUTANE (DBDCB) AND ZINC PYRITHIONE (ZPT) LANXESS DEUTSCHLAND GMBH (DE) 2019-09-05 US claimed
EP-2603786-B1 ISOTONIC BUFFERED COMPOSITION AND METHOD THAT ENABLES COUNTING OF CELLS BECKMAN COULTER INC (US) 2017-03-22 EP claimed
US-9091677-B2 Isotonic buffered composition and method that enables counting of cells BECKMAN COULTER, INC. (US) 2015-07-28 US claimed
CN-104126596-A Antibacterial composition and application thereof SHANGHAI RUNHE NANO MATERIAL SCIENCE & TECHNOLOGY CO LTD 2014-11-05 CN claimed
US-20120034640-A1 Isotonic Buffered Composition and Method that Enables Counting of Cells BECKMAN COULTER, INC. (US) 2012-02-09 US claimed
EP-2106418-A1 GLUING AND SEALING COMPOUNDS HAVING ANTIMICROBIAL PROPERTIES THOR GmbH (DE) 2009-10-07 EP claimed
WO-2008080963-A1 GLUING AND SEALING COMPOUNDS HAVING ANTIMICROBIAL PROPERTIES THOR GMBH (DE) 2008-07-10 WO claimed
WO-2007030409-A2 IN-CAN AND DRY COATING ANTIMICROBIAL COMPOSITIONS HAVING HYDROXY ANALOGS OF METHIONINE AND DERIVATIVES NOVUS INTERNATIONAL INC. (US) 2007-03-15 WO claimed
US-20070053866-A1 IN-CAN AND DRY COATING ANTIMICROBIAL COMPOSITIONS HAVING HYDROXY ANALOGS OF METHIONINE AND DERIVATIVES NOVUS INTERNATIONAL INC. (US) 2007-03-08 US claimed
EP-1273653-A1 Etherdiamines or N-alkyl-diaminopropane or their mixture as lubricants Polygon Chemie AG (CH) 2003-01-08 EP claimed
EP-0919125-B1 Synergistic antimicrobial composition CALGON CORP (US) 2002-05-29 EP claimed
EP-1197544-A1 Conveyor or chain lubricant based on esters Polygon Chemie AG (CH) 2002-04-17 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070053866-A1 IN-CAN AND DRY COATING ANTIMICROBIAL COMPOSITIONS HAVING HYDROXY ANALOGS OF METHIONINE AND DERIVATIVES BHMT2, INMT, AHCY TSHR 2979/4885ALDH1A1 2358/4885TDP1 3450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.